ATHIRA PHARMA Trademark

Trademark Overview

On Tuesday, April 18, 2023, a trademark application was filed for ATHIRA PHARMA with the United States Patent and Trademark Office. The USPTO has given the ATHIRA PHARMA trademark a serial number of 97894381. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 1, 2024. This trademark is owned by Athira Pharma, Inc.. The ATHIRA PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; pharmaceutical drug development services
athira pharma

General Information

Serial Number97894381
Word MarkATHIRA PHARMA
Filing DateTuesday, April 18, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

NOT AVAILABLE"PHARMA"
Goods and ServicesPharmaceutical research and development; pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAthira Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98195
Party NameAthira Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98195

Trademark Events

Event DateEvent Description
Thursday, May 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 21, 2023NEW APPLICATION ENTERED
Thursday, May 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, May 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Thursday, December 28, 2023NON-FINAL ACTION WRITTEN
Thursday, December 28, 2023NON-FINAL ACTION E-MAILED
Thursday, December 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 26, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 26, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

pharma athira pharmaceutical development services drug research